2Tohen M, Shelton R, ToUefson GD, et al. Olanzaplne plus fluoxetine: double-blind and open-label results in treatment-resistant mafor depressive disorder. European N 1999(9):246. 被引量：1
2Keck PE, McElroy SL. New approaches in managing bipolar depression. J Clin Psychiatryj 2003; 64 [Suppl, 1]: 13- 18. 被引量：1
3GEAA Group. Algorithm for the management of depression based on the antidepressant combinations. Acta Psychiatr Scand. 2005; 112 [Suppl, 428]: 36. 被引量：1
4de la Gandara J, Aguera L, Rojo JE, et al. Use of antide- pressant combinations: which, When and why? Results of a spanish survey. Acta Psychiatr Scand. 2005; 112 [Suppl, 428] : 32-35. 被引量：1
5Ros S, Aguera L, de la Gandara J, et al. Potentiation strategies for treatment-resistant depression. Acta Psychiatr Scand, 2005; 112 [Suppl, 428]: 14-24. 被引量：1
1Miller A H Maletic V,Raison.C.I. Inflammation and it'sdiscontents; the role of cytolcines in the pothophysiology of major depression[J]Biol.Psy- chiatry, 2009,65(9) : 732-741. 被引量：1
3Gibbons R D, Brown C H, Hurk,et al, Suicidal thoughts and behavior with antidepressant treatment reanalysis of the randomized placebo- controlled studies of fluoxetine and venlafaxine [J].Arch gen Psychiatry, 2012,69(6):550-587. 被引量：1
